Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Feb;57(1):105-13.

Studies on antistreptolysin O activity generated in serum by microorganisms

Studies on antistreptolysin O activity generated in serum by microorganisms

K C Watson et al. Br J Exp Pathol. 1976 Feb.

Abstract

An antistreptolysin factor (ASF) was generated in normal human serum by the growth of Staph, aureus and Pseud, aeruginosa. Alpha toxin producing strains of the former were usually positive but activity was not restricted to such strains. Positive strains produce cholesterol esterase which was obtained from DEAE-cellulose column fractions of 18 h broth cultures. Antistreptolysin factor develops slowly in serum, being maximal between the 5th and 10th days and is associated with alterations and disappearance of beta lipoproteins on gel electrophoresis. Activity also appeared in beta lipoproteins precipitated from normal serum with dextran sulphate and redissolved in nutrient broth before inoculation with Staph, aureus. The slow appearance of antistreptolysin activity in serum appears to be due to an esterase inhibitor which is present in high concentrations in some sera. Activity is also modified by the production of a staphylococcal fraction capable of binding to the antistreptolysin factor and reducing its activity. It is suggested that antistreptolysin factor which can be demonstrated in small amounts in normal human serum represents a readily available non-specific defence mechanism capable of binding to certain bacterial products and possible to other foreign protein molecules.

PubMed Disclaimer

References

    1. Lancet. 1975 Feb 8;1(7902):308-10 - PubMed
    1. Biochem Biophys Res Commun. 1974 Dec 23;61(4):1283-8 - PubMed
    1. Biochem J. 1974 Apr;140(1):95-8 - PubMed
    1. Infect Immun. 1974 Jul;10(1):54-9 - PubMed
    1. Nature. 1974 Jul 19;250(463):230-1 - PubMed

MeSH terms

LinkOut - more resources